{"id":353686,"date":"2025-08-28T09:39:57","date_gmt":"2025-08-28T09:39:57","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-incyte-corporation\/"},"modified":"2025-08-28T09:39:57","modified_gmt":"2025-08-28T09:39:57","slug":"how-to-buy-incyte-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/","title":{"rendered":"How to buy Incyte Corporation (INCY) shares &#8211; Investment in Incyte Corporation (INCY) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-353686","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Incyte Corporation (INCY) Shares - Investment in Incyte Corporation (INCY) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Incyte Corporation (INCY) Shares - Investment in Incyte Corporation (INCY) Stock"},"description":"Learn how to buy Incyte Corporation (INCY) shares and invest in INCY stock. Discover current price, trends, risks, and growth potential for this biopharmaceutical leader.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Incyte Corporation (INCY) shares and invest in INCY stock. Discover current price, trends, risks, and growth potential for this biopharmaceutical leader."},"intro":"Thinking about investing in a company that's revolutionizing cancer treatment? Incyte Corporation stands at the forefront of precision medicine, developing life-changing therapies for patients worldwide. With strong recent earnings and innovative drug pipeline, this biotech leader offers unique opportunities for savvy investors looking to tap into the growing healthcare sector.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a company that's revolutionizing cancer treatment? Incyte Corporation stands at the forefront of precision medicine, developing life-changing therapies for patients worldwide. With strong recent earnings and innovative drug pipeline, this biotech leader offers unique opportunities for savvy investors looking to tap into the growing healthcare sector."},"body_html":"<h2>\ud83d\udcc8 Incyte Stock: Current Price and Market Position<\/h2> <p>As of August 28, 2025, Incyte Corporation (INCY) trades at <strong>$84.84<\/strong> on the NASDAQ exchange. The company has demonstrated remarkable resilience in the biotech sector, currently sitting just 2.1% below its 52-week high of $87.24.<\/p> <p><strong>Mark your calendar: October 2025 is critical<\/strong> - that's when Incyte is expected to release its next quarterly earnings report. Historically, these reports have significantly moved the stock price, making this a key date for both current shareholders and potential investors.<\/p> <h3>How Earnings Reports Impact INCY Stock<\/h3> <p>Looking at recent performance patterns reveals valuable insights for timing your investment:<\/p> <ul> <li><strong>April 29, 2025<\/strong>: Q1 earnings release with EPS of $1.16 beating estimates by $0.15 - stock gained momentum<\/li> <li><strong>July 29, 2025<\/strong>: Q2 earnings showing $1.57 adjusted EPS (vs $1.39 expected) - strong positive reaction<\/li> <li>Revenue growth of 16% year-over-year to $1.22 billion demonstrated operational strength<\/li> <\/ul> <p>The pattern shows consistent earnings beats, suggesting management's guidance is conservative and actual performance often exceeds expectations.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2> <p>Incyte shares have shown impressive stability amid market volatility, with a <strong>3.03% return over the past year<\/strong> while the broader healthcare sector declined 10.83%. Here's the breakdown:<\/p> <p><strong>January-March 2025<\/strong>: Consolidation phase around $68-72 range<br\/> <strong>April 2025<\/strong>: Breakout following strong Q1 earnings, reaching $78<br\/> <strong>May-July 2025<\/strong>: Steady climb to $82-85 range on continued optimism<br\/> <strong>August 2025<\/strong>: Testing resistance near 52-week highs at $84.84<\/p> <p>The stock's average price over the last 52 weeks has been $68.60, indicating the current price represents a significant premium - a strong bullish signal.<\/p> <h3>Why the upward momentum?<\/h3> <ul> <li><strong>Jakafi sales growth<\/strong>: 8% year-over-year increase to $763.8 million in Q2<\/li> <li><strong>Opzelura explosion<\/strong>: 35% sales growth reaching $164.5 million<\/li> <li><strong>Strong cash position<\/strong>: $2.4 billion providing financial flexibility<\/li> <li><strong>Analyst upgrades<\/strong>: EPS forecasts increased from $4.75 to $5.06 for FY2025<\/li> <\/ul> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst consensus and company fundamentals, here's what to expect:<\/p> <p><strong>2025 Year-End<\/strong>: $81-85 range (maintaining current levels with potential slight upside)<br\/> <strong>2026<\/strong>: $78-83 (consolidation phase as market digests growth)<br\/> <strong>2028<\/strong>: $70-75 (moderate decline as patent concerns emerge)<br\/> <strong>2030<\/strong>: $60-65 (long-term pressure from competition)<\/p> <p><strong>Verdict<\/strong>: HOLD for current investors, WAIT for better entry points for new buyers<\/p> <p>The wide analyst target range ($60-107) reflects significant uncertainty about drug pipeline success and competitive pressures.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>Patent expiration<\/strong>: Jakafi faces eventual patent cliff<\/li> <li><strong>Regulatory challenges<\/strong>: FDA approvals can be unpredictable<\/li> <li><strong>Competition<\/strong>: New entrants in myelofibrosis treatment space<\/li> <li><strong>R&D dependency<\/strong>: Heavy reliance on pipeline success<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Earnings momentum<\/strong>: Consistent beats in recent quarters<\/li> <li><strong>Product diversification<\/strong>: Successful Opzelura launch reducing Jakafi dependency<\/li> <li><strong>Strong cash position<\/strong>: $2.4 billion for strategic acquisitions<\/li> <li><strong>Industry tailwinds<\/strong>: Growing precision medicine market<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Wait for pullback<\/strong>: Current prices near 52-week highs suggest patience<\/li> <li><strong>Dollar-cost average<\/strong>: Consider small, regular investments rather than lump sum<\/li> <li><strong>Set price alerts<\/strong>: Buy if stock drops to $75-78 support zone<\/li> <li><strong>Diversify exposure<\/strong>: Limit biotech allocation to 5-10% of portfolio<\/li> <\/ol> <p>Humorous take: \"Trading INCY is like waiting for clinical trial results - sometimes you need to be patient for that breakthrough moment!\"<\/p> <h2>\u2705 How to Buy Incyte Corporation (INCY) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ listings and competitive fees<\/td><\/tr> <tr><td>2<\/td><td>Open and fund your account<\/td><td>Start with an amount you're comfortable risking<\/td><\/tr> <tr><td>3<\/td><td>Research INCY thoroughly<\/td><td>Understand the company's products and risks<\/td><\/tr> <tr><td>4<\/td><td>Set your entry strategy<\/td><td>Use limit orders to control purchase price<\/td><\/tr> <tr><td>5<\/td><td>Monitor and manage position<\/td><td>Set stop-losses and profit targets<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>For those beginning their investment journey, Pocket Option offers several advantages that make accessing stocks like INCY more accessible:<\/p> <ul> <li><strong>Minimum deposit of just $5<\/strong> allows you to test strategies with minimal risk<\/li> <li><strong>Rapid verification process<\/strong> with single-document KYC gets you trading quickly<\/li> <li><strong>Multiple withdrawal options<\/strong> including cryptocurrencies and e-wallets<\/li> <li><strong>User-friendly platform<\/strong> designed for beginners without overwhelming complexity<\/li> <\/ul> <p>The platform's low barrier to entry makes it ideal for investors who want to start small while learning the markets.<\/p> <h2>\ud83c\udf0d Incyte in 2025: Precision Medicine Pioneer<\/h2> <p>Incyte Corporation dominates the precision medicine space with its innovative approach to cancer treatment. The company's business model focuses on <a href=\"https:\/\/dcfmodeling.com\/products\/incy-business-model-canvas\">targeted therapies for oncology and rare diseases<\/a>, with genomic testing coverage reaching 89% of advanced cancer patients.<\/p> <p>The company's flagship drug <strong>Jakafi<\/strong> generates approximately $1.74 billion annually, while newer products like <strong>Opzelura<\/strong> are showing explosive growth of 35% year-over-year. With <a href=\"https:\/\/www.fiercepharma.com\/pharma\/incyte-ceo-turn-lot-cards-2025-eyes-2-types-deals\">four product launches and four pivotal readouts planned for 2025<\/a>, the company continues to innovate in both cancer and immunology.<\/p> <p><strong>Interesting Fact for 2025<\/strong>: Incyte's research shows that their precision medicine approach has achieved a remarkable 93.7% targeted therapy match rate through molecular profiling, meaning almost all patients receiving genomic testing get matched with an appropriate targeted treatment!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Incyte Stock: Current Price and Market Position<\/h2>\n<p>As of August 28, 2025, Incyte Corporation (INCY) trades at <strong>$84.84<\/strong> on the NASDAQ exchange. The company has demonstrated remarkable resilience in the biotech sector, currently sitting just 2.1% below its 52-week high of $87.24.<\/p>\n<p><strong>Mark your calendar: October 2025 is critical<\/strong> &#8211; that&#8217;s when Incyte is expected to release its next quarterly earnings report. Historically, these reports have significantly moved the stock price, making this a key date for both current shareholders and potential investors.<\/p>\n<h3>How Earnings Reports Impact INCY Stock<\/h3>\n<p>Looking at recent performance patterns reveals valuable insights for timing your investment:<\/p>\n<ul>\n<li><strong>April 29, 2025<\/strong>: Q1 earnings release with EPS of $1.16 beating estimates by $0.15 &#8211; stock gained momentum<\/li>\n<li><strong>July 29, 2025<\/strong>: Q2 earnings showing $1.57 adjusted EPS (vs $1.39 expected) &#8211; strong positive reaction<\/li>\n<li>Revenue growth of 16% year-over-year to $1.22 billion demonstrated operational strength<\/li>\n<\/ul>\n<p>The pattern shows consistent earnings beats, suggesting management&#8217;s guidance is conservative and actual performance often exceeds expectations.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2>\n<p>Incyte shares have shown impressive stability amid market volatility, with a <strong>3.03% return over the past year<\/strong> while the broader healthcare sector declined 10.83%. Here&#8217;s the breakdown:<\/p>\n<p><strong>January-March 2025<\/strong>: Consolidation phase around $68-72 range<br \/> <strong>April 2025<\/strong>: Breakout following strong Q1 earnings, reaching $78<br \/> <strong>May-July 2025<\/strong>: Steady climb to $82-85 range on continued optimism<br \/> <strong>August 2025<\/strong>: Testing resistance near 52-week highs at $84.84<\/p>\n<p>The stock&#8217;s average price over the last 52 weeks has been $68.60, indicating the current price represents a significant premium &#8211; a strong bullish signal.<\/p>\n<h3>Why the upward momentum?<\/h3>\n<ul>\n<li><strong>Jakafi sales growth<\/strong>: 8% year-over-year increase to $763.8 million in Q2<\/li>\n<li><strong>Opzelura explosion<\/strong>: 35% sales growth reaching $164.5 million<\/li>\n<li><strong>Strong cash position<\/strong>: $2.4 billion providing financial flexibility<\/li>\n<li><strong>Analyst upgrades<\/strong>: EPS forecasts increased from $4.75 to $5.06 for FY2025<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst consensus and company fundamentals, here&#8217;s what to expect:<\/p>\n<p><strong>2025 Year-End<\/strong>: $81-85 range (maintaining current levels with potential slight upside)<br \/> <strong>2026<\/strong>: $78-83 (consolidation phase as market digests growth)<br \/> <strong>2028<\/strong>: $70-75 (moderate decline as patent concerns emerge)<br \/> <strong>2030<\/strong>: $60-65 (long-term pressure from competition)<\/p>\n<p><strong>Verdict<\/strong>: HOLD for current investors, WAIT for better entry points for new buyers<\/p>\n<p>The wide analyst target range ($60-107) reflects significant uncertainty about drug pipeline success and competitive pressures.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>Patent expiration<\/strong>: Jakafi faces eventual patent cliff<\/li>\n<li><strong>Regulatory challenges<\/strong>: FDA approvals can be unpredictable<\/li>\n<li><strong>Competition<\/strong>: New entrants in myelofibrosis treatment space<\/li>\n<li><strong>R&#038;D dependency<\/strong>: Heavy reliance on pipeline success<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Earnings momentum<\/strong>: Consistent beats in recent quarters<\/li>\n<li><strong>Product diversification<\/strong>: Successful Opzelura launch reducing Jakafi dependency<\/li>\n<li><strong>Strong cash position<\/strong>: $2.4 billion for strategic acquisitions<\/li>\n<li><strong>Industry tailwinds<\/strong>: Growing precision medicine market<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Wait for pullback<\/strong>: Current prices near 52-week highs suggest patience<\/li>\n<li><strong>Dollar-cost average<\/strong>: Consider small, regular investments rather than lump sum<\/li>\n<li><strong>Set price alerts<\/strong>: Buy if stock drops to $75-78 support zone<\/li>\n<li><strong>Diversify exposure<\/strong>: Limit biotech allocation to 5-10% of portfolio<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading INCY is like waiting for clinical trial results &#8211; sometimes you need to be patient for that breakthrough moment!&#8221;<\/p>\n<h2>\u2705 How to Buy Incyte Corporation (INCY) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ listings and competitive fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Open and fund your account<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Research INCY thoroughly<\/td>\n<td>Understand the company&#8217;s products and risks<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Set your entry strategy<\/td>\n<td>Use limit orders to control purchase price<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Monitor and manage position<\/td>\n<td>Set stop-losses and profit targets<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>For those beginning their investment journey, Pocket Option offers several advantages that make accessing stocks like INCY more accessible:<\/p>\n<ul>\n<li><strong>Minimum deposit of just $5<\/strong> allows you to test strategies with minimal risk<\/li>\n<li><strong>Rapid verification process<\/strong> with single-document KYC gets you trading quickly<\/li>\n<li><strong>Multiple withdrawal options<\/strong> including cryptocurrencies and e-wallets<\/li>\n<li><strong>User-friendly platform<\/strong> designed for beginners without overwhelming complexity<\/li>\n<\/ul>\n<p>The platform&#8217;s low barrier to entry makes it ideal for investors who want to start small while learning the markets.<\/p>\n<h2>\ud83c\udf0d Incyte in 2025: Precision Medicine Pioneer<\/h2>\n<p>Incyte Corporation dominates the precision medicine space with its innovative approach to cancer treatment. The company&#8217;s business model focuses on <a href=\"https:\/\/dcfmodeling.com\/products\/incy-business-model-canvas\">targeted therapies for oncology and rare diseases<\/a>, with genomic testing coverage reaching 89% of advanced cancer patients.<\/p>\n<p>The company&#8217;s flagship drug <strong>Jakafi<\/strong> generates approximately $1.74 billion annually, while newer products like <strong>Opzelura<\/strong> are showing explosive growth of 35% year-over-year. With <a href=\"https:\/\/www.fiercepharma.com\/pharma\/incyte-ceo-turn-lot-cards-2025-eyes-2-types-deals\">four product launches and four pivotal readouts planned for 2025<\/a>, the company continues to innovate in both cancer and immunology.<\/p>\n<p><strong>Interesting Fact for 2025<\/strong>: Incyte&#8217;s research shows that their precision medicine approach has achieved a remarkable 93.7% targeted therapy match rate through molecular profiling, meaning almost all patients receiving genomic testing get matched with an appropriate targeted treatment!<\/p>\n"},"faq":[{"question":"What is Incyte Corporation's main business?","answer":"Incyte is a biopharmaceutical company that develops and commercializes proprietary therapeutics, primarily focused on oncology and rare diseases using precision medicine approaches."},{"question":"How often does INCY pay dividends?","answer":"Incyte does not currently pay dividends, as the company reinvests profits into research and development of new therapies."},{"question":"What are the biggest risks for INCY investors?","answer":"The main risks include patent expirations, regulatory challenges, intense competition, and dependence on successful drug pipeline development."},{"question":"How has INCY performed compared to the broader market?","answer":"Over the past year, INCY has gained 3.03% while the healthcare sector declined 10.83%, showing relative outperformance."},{"question":"What makes Incyte different from other biotech companies?","answer":"Incyte's focus on precision medicine and their high success rate in matching patients with targeted therapies (93.7% match rate) sets them apart in the biotech space."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is Incyte Corporation's main business?","answer":"Incyte is a biopharmaceutical company that develops and commercializes proprietary therapeutics, primarily focused on oncology and rare diseases using precision medicine approaches."},{"question":"How often does INCY pay dividends?","answer":"Incyte does not currently pay dividends, as the company reinvests profits into research and development of new therapies."},{"question":"What are the biggest risks for INCY investors?","answer":"The main risks include patent expirations, regulatory challenges, intense competition, and dependence on successful drug pipeline development."},{"question":"How has INCY performed compared to the broader market?","answer":"Over the past year, INCY has gained 3.03% while the healthcare sector declined 10.83%, showing relative outperformance."},{"question":"What makes Incyte different from other biotech companies?","answer":"Incyte's focus on precision medicine and their high success rate in matching patients with targeted therapies (93.7% match rate) sets them apart in the biotech space."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Incyte Corporation (INCY) shares - Investment in Incyte Corporation (INCY) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Incyte Corporation (INCY) shares - Investment in Incyte Corporation (INCY) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T09:39:57+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Incyte Corporation (INCY) shares &#8211; Investment in Incyte Corporation (INCY) stock\",\"datePublished\":\"2025-08-28T09:39:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/\",\"name\":\"How to buy Incyte Corporation (INCY) shares - Investment in Incyte Corporation (INCY) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-28T09:39:57+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Incyte Corporation (INCY) shares &#8211; Investment in Incyte Corporation (INCY) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Incyte Corporation (INCY) shares - Investment in Incyte Corporation (INCY) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Incyte Corporation (INCY) shares - Investment in Incyte Corporation (INCY) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T09:39:57+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Incyte Corporation (INCY) shares &#8211; Investment in Incyte Corporation (INCY) stock","datePublished":"2025-08-28T09:39:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/","name":"How to buy Incyte Corporation (INCY) shares - Investment in Incyte Corporation (INCY) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-28T09:39:57+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-incyte-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Incyte Corporation (INCY) shares &#8211; Investment in Incyte Corporation (INCY) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":353734,"slug":"how-to-buy-incyte-corporation","post_title":"Comment acheter des actions Incyte Corporation (INCY) - Investir dans les actions Incyte Corporation (INCY)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"it_IT":{"locale":"it_IT","id":353736,"slug":"how-to-buy-incyte-corporation","post_title":"Come acquistare azioni Incyte Corporation (INCY) - Investire in azioni Incyte Corporation (INCY)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"pl_PL":{"locale":"pl_PL","id":353738,"slug":"how-to-buy-incyte-corporation","post_title":"Jak kupi\u0107 akcje Incyte Corporation (INCY) - Inwestycja w akcje Incyte Corporation (INCY)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"es_ES":{"locale":"es_ES","id":353733,"slug":"how-to-buy-incyte-corporation","post_title":"C\u00f3mo comprar acciones de Incyte Corporation (INCY) - Inversi\u00f3n en acciones de Incyte Corporation (INCY)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"th_TH":{"locale":"th_TH","id":353740,"slug":"how-to-buy-incyte-corporation","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Incyte Corporation (INCY) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Incyte Corporation (INCY)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"tr_TR":{"locale":"tr_TR","id":353735,"slug":"how-to-buy-incyte-corporation","post_title":"Incyte Corporation (INCY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Incyte Corporation (INCY) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"vt_VT":{"locale":"vt_VT","id":353739,"slug":"how-to-buy-incyte-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Incyte Corporation (INCY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Incyte Corporation (INCY)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-incyte-corporation\/"},"pt_AA":{"locale":"pt_AA","id":353737,"slug":"how-to-buy-incyte-corporation","post_title":"Como comprar a\u00e7\u00f5es da Incyte Corporation (INCY) - Investimento em a\u00e7\u00f5es da Incyte Corporation (INCY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-incyte-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/353686","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=353686"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/353686\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=353686"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=353686"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=353686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}